Metronidazole as a radiosensitizer and high-dose radiation in advanced vulvovaginal malignancies, a pilot study
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 16 (1) , 117-128
- https://doi.org/10.1016/0090-8258(83)90017-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Metronidazole and interstitial implantation in the treatment of extensive recurrent head and neck cancersCancer, 1981
- Hyperbaric oxygen as a radiation sensitizer for carcinoma of the cervixInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Short course high fractional dose irradiation in advanced and recurrent head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Correlation between retinal and pelvic vascular status: A determinant factor in patients undergoing pelvic irradiation for gynecologic malignancyAmerican Journal of Obstetrics and Gynecology, 1979
- Dosimetric considerations in irradiation of carcinoma of the VaginaInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Radiation and High-Dose Metronidazole in Supratentorial GlioblastomasNew England Journal of Medicine, 1976
- Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cellsBritish Journal of Cancer, 1976
- Phase 1 Study of High-Dose Metronidazole: A SpecificIn VivoandIn VitroRadiosensitizer of Hypoxic CellsRadiology, 1975
- Irradiation of 'in-situ' and invasive squamous cell carcinomas of the vaginaCancer, 1971
- Causes, Time of Death, and Sites of Failure in Squamous-Cell Carcinoma of the Uterine Cervix on Intact UterusRadiology, 1967